Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

2.
3.

Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma.

Apte SM, Fan D, Killion JJ, Fidler IJ.

Clin Cancer Res. 2004 Feb 1;10(3):897-908.

4.
6.

Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.

Uehara H, Kim SJ, Karashima T, Shepherd DL, Fan D, Tsan R, Killion JJ, Logothetis C, Mathew P, Fidler IJ.

J Natl Cancer Inst. 2003 Mar 19;95(6):458-70.

PMID:
12644539
9.

Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.

Huang SF, Kim SJ, Lee AT, Karashima T, Bucana C, Kedar D, Sweeney P, Mian B, Fan D, Shepherd D, Fidler IJ, Dinney CP, Killion JJ.

Cancer Res. 2002 Oct 15;62(20):5720-6.

10.

Targeted molecular therapy for oral cancer with epidermal growth factor receptor blockade: a preliminary report.

Myers JN, Holsinger FC, Bekele BN, Li E, Jasser SA, Killion JJ, Fidler IJ.

Arch Otolaryngol Head Neck Surg. 2002 Aug;128(8):875-9.

PMID:
12162763
11.
12.

Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.

Solorzano CC, Baker CH, Bruns CJ, Killion JJ, Ellis LM, Wood J, Fidler IJ.

Cancer Biother Radiopharm. 2001 Oct;16(5):359-70.

PMID:
11776753
13.

Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma.

Solorzano CC, Baker CH, Tsan R, Traxler P, Cohen P, Buchdunger E, Killion JJ, Fidler IJ.

Clin Cancer Res. 2001 Aug;7(8):2563-72.

14.

Expression of inflammatory cytokines by murine macrophages activated with a new synthetic lipopeptide JT3002.

Kumar R, Eue I, Dong Z, Killion JJ, Fidler IJ.

Cancer Biother Radiopharm. 1997 Oct;12(5):333-40.

PMID:
10851483
15.

Angiogenesis and growth of murine colon carcinoma are dependent on infiltrating leukocytes.

Yoneda J, Killion JJ, Bucana CD, Fidler IJ.

Cancer Biother Radiopharm. 1999 Jun;14(3):221-30.

PMID:
10850306
16.

Intensified regression of colon cancer liver metastases in mice treated with irinotecan and the immunomodulator JBT 3002.

Shinohara H, Bucana CD, Killion JJ, Fidler IJ.

J Immunother. 2000 May-Jun;23(3):321-31.

PMID:
10838661
17.

Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.

Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.

Clin Cancer Res. 2000 Mar;6(3):957-65.

18.

Differential regulation of type IV collagenases and metalloelastase in murine macrophages by the synthetic bacterial lipopeptide JBT 3002.

Kumar R, Xie K, Eue I, Dong Z, Killion JJ, Fidler IJ.

Int J Immunopharmacol. 2000 Jun;22(6):431-43.

PMID:
10727754
20.
22.

Orthotopic models are necessary to predict therapy of transplantable tumors in mice.

Killion JJ, Radinsky R, Fidler IJ.

Cancer Metastasis Rev. 1998-1999;17(3):279-84. Review.

PMID:
10352881
23.

Estimation of plasma beta-2-glycoprotein levels by competitive ELISA.

Balasubramanian K, Killion JJ, Schroit AJ.

Thromb Res. 1998 Oct 15;92(2):91-7.

PMID:
9792117
24.
26.
27.

Activation of cytokine production, tumoricidal properties, and tyrosine phosphorylation of MAPKs in human monocytes by a new synthetic lipopeptide, JBT3002.

Dong Z, Killion JJ, Kumar R, Eue I, Yang X, Lu W, Su B, Fidler IJ.

J Leukoc Biol. 1998 Jun;63(6):766-74.

PMID:
9620671
28.

Specific Th1 cell lines that confer protective immunity against experimental Borrelia burgdorferi infection in mice.

Pride MW, Brown EL, Stephens LC, Killion JJ, Norris SJ, Kripke ML.

J Leukoc Biol. 1998 May;63(5):542-9.

PMID:
9581797
29.

Maintenance of intestinal epithelium structural integrity and mucosal leukocytes during chemotherapy by oral administration of muramyl tripeptide phosphatidylethanolamine.

Killion JJ, Bucana CD, Radinsky R, Dong Z, O'Reilly T, Bilbe G, Tarcsay L, Fidler IJ.

Cancer Biother Radiopharm. 1996 Dec;11(6):363-71.

PMID:
10851497
30.

Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.

Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ.

Clin Cancer Res. 1996 Sep;2(9):1627-36.

31.
32.

In vivo modulation of macrophage tumoricidal activity by oral administration of the liposome-encapsulated macrophage activator CGP 19835A.

Tanguay S, Bucana CD, Wilson MR, Fidler IJ, von Eschenbach AC, Killion JJ.

Cancer Res. 1994 Nov 15;54(22):5882-8.

33.

Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells.

Tanguay S, Killion JJ.

Lymphokine Cytokine Res. 1994 Aug;13(4):259-63.

PMID:
7999925
35.
36.

Prevention of chemotherapy- or X-irradiation-induced monocytopenia by oral administration of lipophilic muramyl tripeptide.

Killion JJ, Brown DR, Wilson MR, Lloyd MM, Fidler IJ.

Oncol Res. 1994;6(8):357-64.

PMID:
7894085
37.

The immunogenic properties of drug-resistant murine tumor cells do not correlate with expression of the MDR phenotype.

Killion JJ, Radinsky R, Dong Z, Fishbeck R, Whitworth P, Fidler IJ.

Cancer Immunol Immunother. 1993 Jun;36(6):381-6.

PMID:
8098991
38.

Metastatic model for human prostate cancer using orthotopic implantation in nude mice.

Stephenson RA, Dinney CP, Gohji K, Ordóñez NG, Killion JJ, Fidler IJ.

J Natl Cancer Inst. 1992 Jun 17;84(12):951-7.

PMID:
1378502
40.
42.

Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362.

Dinney CP, Bucana CD, Utsugi T, Fidler IJ, von Eschenbach AC, Killion JJ.

Cancer Res. 1991 Jul 15;51(14):3741-7.

43.
44.

Superior antiproliferative effects mediated by interferon-alpha entrapped in liposomes against a newly established human lung cancer cell line.

Shin DM, Fidler IJ, Bucana CD, Fan D, Hong WK, Killion JJ.

J Biol Response Mod. 1990 Aug;9(4):355-60.

PMID:
2395001
45.

The development of liposomes containing interferon alpha for the intravesical therapy of human superficial bladder cancer.

Frangos DN, Killion JJ, Fan D, Fishbeck R, von Eschenbach AC, Fidler IJ.

J Urol. 1990 Jun;143(6):1252-6.

PMID:
2342197
46.
47.

Augmentation of antiproliferative activity of interferon alfa against human bladder tumor cell lines by encapsulation of interferon alfa within liposomes.

Killion JJ, Fan D, Bucana CD, Frangos DN, Price JE, Fidler IJ.

J Natl Cancer Inst. 1989 Sep 20;81(18):1387-92.

PMID:
2778824
48.

Modern views of metastasis.

Killion JJ.

Cancer Cells. 1989 Sep;1(1):36-8. Review. No abstract available.

PMID:
2701362
49.

Mechanisms of cancer metastasis.

Killion JJ, Fidler IJ.

Arzneimittelforschung. 1989 Aug;39(8A):1031-4. Review. No abstract available.

PMID:
2684179
50.

The biology of tumor metastasis.

Killion JJ, Fidler IJ.

Semin Oncol. 1989 Apr;16(2):106-15. Review. No abstract available.

PMID:
2652314

Supplemental Content

Loading ...
Support Center